As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.

On January 15, 2025, the Food and Drug Administration (FDA) amended its color additive regulations by revoking its ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...